Recent Updates
Recently added Catalysts
BSX

Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the third quarter ended September 30,...

Key Takeaway: NATICK, Mass. , Oct. 7 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) will webcast its conference call discussing financial results for the third quarter ended September 30, 2010 on Tuesday, October 19 , at 5:30 p.m. ET . The timing of the call was set to av

Full Press Release Details

NATICK, Mass. , Oct. 7 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) will webcast its conference call discussing financial results for the third quarter ended September 30, 2010 on Tuesday, October 19 , at 5:30 p.m. ET . The timing of the call was set to avoid conflicts with previously announced peer company conference calls.
The call will be hosted by Ray Elliott , President and Chief Executive Officer, and Jeff Capello , Executive Vice President and Chief Financial Officer.
The live webcast and archived replay of this call will be available at www.bostonscientific.com in the Investor Relations section. The webcast will also be distributed over Thomson Financial's Investor Distribution Network via two locations: www.earnings.com , which is accessible to the public, and www.streetevents.com , a password-protected event management site.
To ensure a timely connection to the live webcast, it is recommended that users register at least 15 minutes before the webcast begins. A replay of the webcast will be available beginning at approximately 7:30 p.m. ET on October 19 and will be available for one year.
A press release announcing the financial results for the third quarter will be issued after the close of the market on Tuesday, October 19 .
About Boston Scientific
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com .
CONTACT: Paul Donovan
508-650-8541 (office)
508-667-5165 (mobile)
Media Relations
Boston Scientific Corporation
Larry Neumann
508-650-8696 (office)
Investor Relations
Boston Scientific Corporation
SOURCE Boston Scientific Corporation

21 %

Last updated: Oct 7, 2010